NEW YORK (GenomeWeb) – Interleukin Genetics this week filed documents with the US Securities and Exchange Commission to complete the process of delisting and deregistering its securities. The Waltham, Massachusetts-based firm announced in late July that it would be liquidating its assets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.